Day 3 – Physician Meet – Scientific Program
Saturday, October 28th, 2023
08.00 AM – 09.30 AM | APBMT Business Meeting | |
09.00 AM – 09.40 AM |
Plenary Session 2 Cellular Therapy for Acute Leukemia Chairman : |
|
09.40 AM – 10.10 AM | Break | |
10.10 AM – 12.10 PM |
Session 6 Chairman : Bor-Sheng Ko (Taipei) |
Session 7 Chairman : Amir Ali Hamidieh (Tehran) |
10.10 AM – 10.40 AM | Auto HSCT for Autoimmune Disease Barbara Withers, MBBS, FRACP, FRCPA (Sydney) |
Fungal Infection Abi Manesh, MD (Vellore) |
10.40 AM – 11.10 AM | CAR-T for Autoimmune Disease Hu Yongxian, MD, Ph.D (Hangzhou) |
CMV infection after HSCT Jae Ho Yoon, MD, Ph.D (Seoul) |
11.10 AM – 11.40 AM | HSCT for Myeloma (Induction & Maintenance) Chen Yunxin, MBBS, MRCP(UK), FRCPath(Haem), MCI (Singapore) |
How We Transplant in Hepatitis B Carrier Patients? Yi Chang Liu, MD (Kaohsiung) |
11.40 AM- 12.10 PM | Auto Transplant for Lymphoma in the Era of CAR-T Anna Sureda, MD, Ph.D (Barcelona) |
Late infection and Immunization Nopporn Apiwattanakul, MD, Ph.D (Bangkok) |
12.10 PM – 1.10 PM | Industry Sponsored Lunch Symposium – Terumo |
|
01.10 PM – 03.10 PM |
Session 8 Chairman : Alberto Mussetti, MD (Barcelona) |
Session 9 Chairman : |
03.10 PM – 03.30 PM | Break | |
03.30 PM – 04.30 PM | General Assembly Meeting | |
04.30 PM – 06.30 PM |
Session 10 Chairman : Tran-Der Tan, MD (Taipei) |
Session 11 Chairman : Nopporn Apiwattanakul, MD, Ph.D (Bangkok) |
04.30 PM – 05.00 PM | T-cell Replete Haplo HCT for Acute Leukemia Dinesh Burani, MBBS, MD, DM, FRCPA (New Delhi) |
Advances in Acute GVHD Reaction Joon Ho Moon, MD, PhD (Daegu) |
05.00 PM – 05.30 PM | Ex Vivo Lymphoid Cell Selection for Haplo HCT in Hematological Malignancies Linn Yeh-Ching, MBBS, MRCP (Singapore) |
Advances in Chronic GVHD Treatment Hyoung Jin Kang, MD, MS, Ph.D (Seoul) |
05.30 PM – 06.00 PM | Allo HSCT for AML in the era of genomics Lim Zi Yi, MD (Singapore) |
Strategies for augmenting graft vs tumor effect post-transplant Xavier Cheng-Hong Tsai, MD, MSc, Ph.D (Taipei) |
06.00 PM – 06.30 PM | HSCT for Ph(+)ALL/ CML in the Era of TKI Prof. David Yeung, BSc, MBBS, UNSW, PhD, FRACP, FRCPA (Adelaide) |
The role of microbiota in immunity and hematopoiesis after HSCT Daigo Hashimoto, MD, Ph.D (Sapporo) |
06.30 PM – 07.00 PM | Break | |
07.00 PM – 08:00 PM | Industry Sponsored Dinner Symposium – Gilead & Kite | |
08.00 PM Onwards |
Cultural Night All delegates and Participants |